CHESTGuidelines & Topic CollectionsInterstitial Lung Disease

Interstitial Lung Disease

Patient education assets


A bundle of offerings from the ILD Clinician Toolkit

Bridging Specialties™: ILD Clinician Toolkit

Shorten the time to diagnosis for ILDs by using the right resources. In this free toolkit, you'll find:

- ILD diagnosis and management checklist
- Early detection for ILD module
- Decision-making tool module
- Expert videos exploring radiologic features of ILDs

And more!

ACCESS THE TOOLKIT

A bundle of offerings from the ILD Clinician Toolkit

Join the Diffuse Lung Disease and Lung Transplant Network

CHEST Networks are specialty-focused communities that provide forums for leadership, education, and advocacy. This Network enhances the scientific knowledge, evidence-based medicine, and clinical practices for health care providers in the areas of ILDs, lung transplant, occupational health, and pulmonary physiology and rehabilitation.

LEARN MORE »

ILD news and notes

Follow the latest ILD news

INTERSTITIAL LUNG DISEASE SECTION

Updates in evidence for rituximab in interstitial lung disease
Read about two clinical trials that investigated the use of rituximab in patients with severe or progressive autoimmune ILD and patients with systemic sclerosis-associated ILD.

QUALITY IMPROVEMENT PROJECTS

CHEST awards two grants for ILD research
Drs. Kavitha Selvan and Amirahwaty Abdullah received funding to implement quality improvement projects to shorten the time to diagnosis for patients with ILD.

PULMONOLOGY DATA TRENDS 2023

Progressive Pulmonary Fibrosis: Understanding Its Many Forms
Explore infographics on a new definition of PPF, its pathophysiology, and its associated financial burdens.

LUNG TRANSPLANT SECTION

CLAD prevention in lung transplant recipients: tacrolimus vs cyclosporin
A new study demonstrated that immunosuppressive regimens containing tacrolimus significantly reduced incidence of CLAD diagnosis at 36 months.

OCCUPATIONAL AND ENVIRONMENTAL HEALTH SECTION

Use of low-cost air quality monitors for patients with lung disease
Low-cost qir quality monitors may empower patients to intervene on unsafe household conditions and minimize their risk of poor lung health.

PULMONARY PHYSIOLOGY AND REHABILITATION SECTION

Use of 6-minute walk distance as a clinical trial outcome in ILD
A decline in 6MWT results can represent progression of ILD; ILD-related PH; or musculoskeletal, hematologic, or cardiac etiologies related to the underlying cause of ILD.

Build your ILD expertise

CHEST SEEK™ Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.


CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »